A Retrospective Study on the Role of Diabetes and Metformin in Colorectal Cancer Disease Survival | Zendy

Ravi Ramjeesingh | Zendy; C. Orr | Zendy; Corey Sean Bricks | Zendy; Wilma M. Hopman | Zendy; Nazik Hammad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Retrospective Study on the Role of Diabetes and Metformin in Colorectal Cancer Disease Survival

Author(s) -

Ravi Ramjeesingh,

C. Orr,

Corey Sean Bricks,

Wilma M. Hopman,

Nazik Hammad

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.2809

Subject(s) - metformin , medicine , diabetes mellitus , proportional hazards model , colorectal cancer , retrospective cohort study , cancer , disease , type 2 diabetes , oncology , endocrinology

Recent studies have suggested an effect of metformin on mortality for patients with both diabetes and colorectal cancer (crc). However, the literature is contradictory, with both positive and negative effects being identified. We set out to determine the effect of metformin with respect to prognosis in crc patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research